Latest Funding News

Regis Healthcare has reported a robust FY25 financial performance, marked by significant profit growth and strategic acquisitions, positioning itself for ambitious expansion in Australia’s aged care sector.

Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.

Argo Global Listed Infrastructure Limited reported a remarkable 307% increase in profit for the year ended June 2025, alongside a 269% jump in investment income, underpinning a higher fully franked dividend.

Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share following a profitable FY2025, reinforcing its unique position in the medicinal cannabis sector. Shareholders are invited to participate in a discounted Dividend Reinvestment Plan.

Stockland has amended its final dividend record date to 30 June 2025, confirming robust financial results for the fiscal year with significant profit growth.

Dalrymple Bay Infrastructure Limited (DBI) reports a strong first half of 2025 with increased funds from operations and distributions, underpinned by a stable, inflation-linked revenue model and significant capital investment in terminal maintenance and expansion.

Iltani Resources has identified 16 significant electromagnetic anomalies at its Herberton Project, including 13 near the Orient silver-indium deposit, setting the stage for a multi-phase exploration campaign.

GTN Limited reported a modest revenue decline and a sharper EBITDA drop in FY25 but rewarded shareholders with strong returns including dividends, buybacks, and a significant capital return.

GTN Limited reported a 2% revenue decline to AUD 180.2 million and a net loss after tax of AUD 6.06 million for FY25, alongside a capital return approved by shareholders. The company is navigating operational challenges while positioning for future growth across its global media platform.

Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.

Navigator Global Investments (NGI) reported a strong FY25 with record earnings driven by robust revenue growth and strategic investments, reinforcing its unique position in alternative asset management on the ASX.

Navigator Global Investments Limited (ASX, NGI) reported a robust 80% increase in net profit for FY25, driven by strong performance fees and strategic acquisitions including 1315 Capital Partners. The company also announced key board transitions as it reviews its dividend policy amid growth ambitions.